繁
简
Market+ (iPhone)
Market+ (Android)
Mobile Site
US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Quote Service
Market
Market
Quotes
Quotes
Analysis
Analysis
Commentary
Commentary
Warrants&CBBCs
Warrants&CBBCs
Warrants&CBBCs Overview
Warrants
CBBCs
ETF
ETF
MPF
MPF
Education
Members
Members
About Us
About Us

Leveraged / Inverse ETF

FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Last (HKD)1
Details»
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
Leveraged / Inverse ETF
All
Positive
Inverse
Issuer
Expenses & Facts
Analysis
Calendar Yr Chg
Cumulative Chg
Overview (By Turn.)
Overview (By Asset)
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng TECH Index 4.986
 HKD 		-0.199 -3.838% 279.71M 1.40B 6.590 (-24.340%)
HKD as at 2025/02/25
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng TECH Index 1.782
 HKD 		+0.062 +3.605% 543.60M 966.14M 1.831 (-2.697%)
HKD as at 2025/02/25
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 2.270
 HKD 		+0.034 +1.521% 166.23M 375.91M 2.726 (-16.725%)
HKD as at 2025/02/25
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng Index 5.195
 HKD 		-0.085 -1.610% 34.53M 180.01M 5.000 (+3.906%)
HKD as at 2025/02/25
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Solactive Gold 1-Day Rolling Futures Index 17.960
 HKD 		+0.740 +4.297% 4.24M 76.43M 13.980 (+28.473%)
HKD as at 2025/02/24
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 4.426
 HKD 		+0.054 +1.235% 12.30M 54.76M 4.925 (-10.137%)
HKD as at 2025/02/24
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Nikkei Stock Average Index 63.280
 HKD 		+0.660 +1.054% 205.85K 13.17M 67.238 (-5.886%)
HKD as at 2025/02/25
FI CSOP HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 3.800
 HKD 		+0.032 +0.849% 2.69M 10.21M 4.098 (-7.281%)
HKD as at 2025/02/25
FL2CSOPNASDAQ
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 NASDAQ-100 Index 25.000
 HKD 		-0.320 -1.264% 404.70K 10.04M 25.595 (-2.325%)
HKD as at 2025/02/24
FI2CAMNDQ100
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 0.673
 HKD 		+0.006 +0.900% 14.06M 9.53M 0.748 (-9.979%)
HKD as at 2025/02/24
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng China Enterprises 3.236
 HKD 		-0.074 -2.236% 1.93M 6.29M 3.260 (-0.721%)
HKD as at 2025/02/25
XL2CSOPCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 CSI 300 3.510
 HKD 		-0.052 -1.460% 1.54M 5.42M 3.748 (-6.360%)
HKD as at 2025/02/25
FI2 CSOP HSCEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng China Enterprises 1.742
 HKD 		+0.038 +2.230% 2.62M 4.51M 2.024 (-13.941%)
HKD as at 2025/02/25
XL2 BOS CHINEXT
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 ChiNext Index (HKD)(CNH) 3.402
 HKD 		-0.078 -2.241% 1.30M 4.48M 4.284 (-20.592%)
HKD as at 2025/02/24
XI2CSOPNVDA
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng China Enterprises 40.880
 HKD 		-0.380 -0.921% 64.65K 2.66M N/A
FL2CAMNDQ100
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 NASDAQ-100 Index 32.840
 HKD 		-0.420 -1.263% 33.30K 1.09M 33.689 (-2.520%)
HKD as at 2025/02/24
XI2CSOPCOIN
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Tokyo Stock Price Index 29.180
 HKD 		+2.860 +10.866% 33.26K 978.14K N/A
FI CSOP BTC
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 S&P Bitcoin Futures Index 4.276
 HKD 		+0.106 +2.542% 214.50K 924.49K 5.008 (-14.611%)
HKD as at 2025/02/24
FL2 CSOP NIKKEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Nikkei Stock Average Index 73.360
 HKD 		-0.740 -0.999% 3.64K 264.51K 73.464 (-0.141%)
HKD as at 2025/02/25
FIFBFTTAIWAN
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 FTSE Taiwan RIC Capped Index 4.350
 HKD 		+0.038 +0.881% 12.70K 55.40K 0.550 (+0.801%)
USD as at 2025/02/24
FL2FBFTTAIWAN
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 FTSE Taiwan RIC Capped Index 11.450
 HKD 		0.000 0.000% 0.00 0.00 1.779 (-17.996%)
USD as at 2025/02/24
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2025/06/13 16:08
 
SITEMAP
AASTOCKS.com
 
 
Members
 
About Us
Market
Quotes
 
Analysis
News & Research
 
Commentary
 
Warrants&CBBCs
 
Warrants
 
CBBCs
 
US Stocks
Forex
 
Fund
 
MPF
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1
2
Compare